ACHILLES THERAPEUTICS LIMITED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 8th, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 8th, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the day of November 2020, by and among ACHILLES THERAPEUTICS LIMITED (the “Company”) (Company no. 10167668), CANCER RESEARCH TECHNOLOGY LIMITED (“CRT”) (Company no. 01626049) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor”.
DATED 28th February 2020 - and - COLLABORATION AGREEMENTCollaboration Agreement • January 8th, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledJanuary 8th, 2021 Company Industry Jurisdiction
Eversheds Sutherland (International) LLP One Wood Street London EC2V 7WS United Kingdom T: +44 20 7497 9797 F: +44 20 7919 4919 DX 154280 Cheapside 8 eversheds-sutherland.com Dated: February 21, 2020Lease Agreement • January 8th, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledJanuary 8th, 2021 Company Industry Jurisdiction